Infections in patients undergoing peritoneal dialysis

被引:20
|
作者
Vas, S [1 ]
Oreopoulos, DG [1 ]
机构
[1] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.1016/S0891-5520(05)70171-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Considering experience acquired in the past years, it seems as though physicians have reached plateau in the frequency of peritonitis. A peritonitis rate of 1 every 2 patient years may be acceptable. Further reduction of this peritonitis rate will require inordinately large efforts on all fronts. One will have to consider what are the acceptable costs and risks of peritonitis in patients on peritoneal dialysis. New developments in catheter technology, improved connections, better understanding of patient selection and training programs, improved diagnostic and therapeutic methods in the management of peritonitis, and understanding of the infectious and immune processes are eagerly awaited developments.
引用
收藏
页码:743 / +
页数:33
相关论文
共 50 条
  • [21] Telecare support for patients undergoing chronic peritoneal dialysis
    Cargill, A
    Watson, AR
    PERITONEAL DIALYSIS INTERNATIONAL, 2003, 23 (01): : 91 - 94
  • [22] OUTCOMES OF PATIENTS WITH SYSTEMIC AMYLOIDOSIS UNDERGOING PERITONEAL DIALYSIS
    Yerovi, Estefania
    Gorrin, Maite Rivera
    Burguera, Victor
    Delgado, Maria
    Delgado, Maria
    Pampa, Saul
    Caravaca, Fernando
    Liano, Fernando
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1506 - 1506
  • [23] BETA TRACE PROTEIN IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
    Ruiner, Carola-Ellen
    Boes, Dominik
    Hundt, Felix
    Bohmann, Sylvie
    Woitas, Rainer P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [24] Renal transplantation in patients undergoing chronic peritoneal dialysis
    Fontan, MP
    RodriguezCarmona, A
    Falcon, TG
    Moncalian, J
    Oliver, J
    Valdes, F
    PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (01): : 48 - 51
  • [25] Evaluation of Fibromyalgia Syndrome in Patients Undergoing Peritoneal Dialysis
    Senturk, Taskin
    Sargin, Gokhan
    Akdam, Hakan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] Leptin and proinflammatory cytokines in patients undergoing peritoneal dialysis
    Hilkens, MGEC
    Netea, MG
    Van der Meer, JWM
    Koolen, MI
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (06) : 525 - 526
  • [27] PATTERNS OF ANEMIA MANAGEMENT IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
    Peng, Yi
    Kats, Allyson
    Gilbertson, David T.
    Kim, Deborah
    Monda, Keri L.
    Wetmore, James B.
    Bradbury, Brian D.
    Collins, Allan J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A89 - A89
  • [28] PHARMACOKINETICS OF CEFTAZIDIME IN PATIENTS UNDERGOING PERITONEAL-DIALYSIS
    TOURKANTONIS, A
    NICOLAIDIS, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 263 - 267
  • [29] PHARMACOKINETICS OF METRONIDAZOLE IN PATIENTS UNDERGOING PERITONEAL-DIALYSIS
    CASSEY, JG
    CLARK, DA
    MERRICK, P
    JONES, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (06) : 950 - 951
  • [30] CANDIDA INFECTIONS IN PATIENTS ON MAINTENANCE PERITONEAL-DIALYSIS
    MEYERS, AM
    DISLER, P
    KAY, K
    BLOCH, C
    FURMAN, KI
    KIDNEY INTERNATIONAL, 1977, 11 (04) : 286 - 286